Intestinal Inflammation in Ankylosing Spondylitis and the Effects of Adalimumab on Mucosal Healing

NCT01174186 · clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
30
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Regionshospitalet Silkeborg

Collaborators